Drug Profile
AVI 6002
Alternative Names: AVI-6002; AVI-7357/AVI-7539; AVI-7539/AVI-7357Latest Information Update: 09 Oct 2012
Price :
$50
*
At a glance
- Originator AVI BioPharma; United States Army Medical Research Institute of Infectious Diseases
- Developer Sarepta Therapeutics; United States Army Medical Research Institute of Infectious Diseases
- Class Antisense elements; Antisense oligonucleotides; Antivirals
- Mechanism of Action RNA interference; Viral RNA inhibitors; VP35 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ebola virus infections